BTST Trading Tips for Today: 14th September, 2021

by 5paisa Research Team 13/09/2021

5paisa analysts bring the best intraday ideas, short-term ideas and long-term ideas for you. In the morning we provide best momentum stocks to buy today, while in the last trading hour we provide buy today sell tomorrow (BTST) ideas.

BTST Trading Ideas for Today

1. HCLTECH SEP FUT (HCTTECH)

- Current Market Price: 1,234

- Stop Loss: 1,222

- Target 1: 1,246

- Target 2: 1,255

 

2. ESCORTS SEP FUT  (ESCORTS)

- Current Market Price: 1,465

- Stop Loss: 1,451

- Target: 1,490

 

3. Orient Electric (ORIENTELEC)

- Current Market Price: 354.5

- Stop Loss: 350

- Target: 363

 

4. INDIABULLS HOUSING (IBULHSGFIN)

- Current Market Price: 237.5

- Stop Loss: 234

- Target: 244

 

5. Hemisphere Properties (HEMIPROP)

- Current Market Price: 139

- Stop Loss: 136

- Target: 145

Next Article

Reliance Jio Puts off Smart Phone Launch

Reliance Jio puts off smart phone launch
by 5paisa Research Team 13/09/2021

The shortage of microchips globally has not only impacted the production of auto companies. Another project that has been affected by this shortage of microchips is the proposed launch of the Jio-Phone Next. The Jio-Phone Next is the joint collaboration of Reliance Jio and Google, which has a strategic stake in Reliance Digital.

In a statement to the press, Reliance Industries noted that due to sustained shortage of microchips in the global market, it had put off its proposed launch of the smartphone from Ganesh Chaturthi to Diwali this November. The Jio-Phone Next will be a low cost smartphone which will be affordable yet extremely feature rich. It help catapult millions of 2G customers into digital ready 4G network.

Check: Reliance AGM 2021

Microchips are intelligent transistors that are integral to everything from televisions to microwave ovens to computers to smart phones to cars. These microchips have high-end processing and intelligence capabilities which makes the functioning of most equipment logical and digitally driven. 

This shortage of chips became acute in the last 2 years since the pandemic. There has been a surge in demand for laptops and smartphones as people learn and communicate through Zoom and other videoconferencing software. While demand for microchips has surged, supply is highly complex and takes time to keep pace. Currently, it is that phase when supply is trying to catch with demand.

However, Reliance Jio and Google are already testing the low-cost smartphone with a limited set of users to make it more refined by the time it is officially launched in Diwali. As of now, Reliance has not indicated the price of the smartphone except saying that it would be value for money.

For Reliance, JioPhone Next is their big bet on the “bottom of the pyramid” telecom market by combining an attractive price point with all perks of being a 4G customer. The phone will come with smart features like Google Assistant, auto read-aloud, language translation of on-screen text as well as a high-end camera.

Next Article

Ami Organics IPO Listing

Ami Organics IPO Listing
IPO
by 5paisa Research Team 13/09/2021

Ami Organics had a solid listing on 14 September as it listed at a much better premium than indicated by the GMP and held on to the gains. Ami Organics listed at a premium of 49.18% and traded through the day in a range of Rs.100. The stock closed the day, well above the listing price. With overall subscription of over 64.54X, listing response was in line with the solid subscription. Here is the Ami Organics listing story on 14 September.

AMI Organics IPO price was fixed at the upper end of the band at Rs.610 after the 64.44X subscription. On 14 Sep, the stock of Ami Organics listed on the NSE at a price of Rs.910, a premium of 49.18% over the issue price. On the BSE, the stock listed at a price of Rs.902, a listing premium of 47.87%.

On the NSE, Ami Organics closed at Rs.934.50, a first day closing premium of 53.19% on the issue price. On the BSE, the stock closed at Rs.934.55, a first day closing premium of 53.20% on the issue price.

On Day-1 of listing, Ami Organics touched a high of Rs.966.70 on the NSE and a low of Rs.841. On Day-1, the Ami Organics stock traded a total of 112.15 lakh shares on NSE amounting to value of Rs.1,026.10 crore. On Day-1, Ami Organics was the sixth most liquid stock on the NSE by trading value.

On the BSE, Ami Organics touched a high of Rs.967.25 and a low of Rs.841.20. On BSE, the stock traded a total of 19.46 lakh shares amounting to value of Rs.177.70 crore. At the close of Day-1, Ami Organics had a market capitalization of Rs.3,405 crore with free-float market cap of just Rs.613 crore.

 

Also Read: 

Upcoming IPOs in 2021

IPOs in September

Next Article

Freshworks Plans $912 million IPO in the US Stock Markets

Freshworks IPO
IPO
by 5paisa Research Team 13/09/2021

India’s own home-made rival to Salesforce, Freshworks, will shortly launch a $912 million IPO in the US markets, Freshworks will be targeting an overall valuation of $9 billion for the business. Freshworks started its journey in India, but is currently based out of California, the seat of the technology and digital revolution. 

Freshworks raised its last round of financing almost 2 years back in November 2019. At that time, the company was valued at nearly $3.5 billion. The current valuation sought is nearly 2.6 times its 2019 valuation. However, the pandemic has made technology a lot more integral to business and such kind of value accretion is justified. 

Freshworks counts a number of important PE players as its core investors. The list includes Sequoia Capital, Accel Partners and Tiger Global; all marquee investors in the digital space. Freshworks offers a broad range of business software tools that range from customer relationship management (CRM) to help-desk software. It has also built a SAAS (Software as a service) platform for some of its core customers.

As part of the IPO, Freshworks plans to offer a total of 28.5 million shares at a price range of $28 to $32. At the upper end of the price band, the IPO size works out to $912 million. For the first six months of 2021, Freshworks reported revenues of $169 million and a net loss of $9.8 million. However, the net loss has sharply narrowed from $57 million in the corresponding period last year.

What justifies this steep valuation then? One is the size of the opportunity. As per IDC, the addressable market for Freshworks is close to $120 billion so the headroom is huge. Secondly, it serves over 50,000 customers so the potential to deepen customer ROI is also substantial. Freshworks was co-founded by Girish Mathrubhootham. 

In case you plan to invest in the Freshworks IPO, you can make this US Stock Investment from 5paisa

 

Also Read: 

Upcoming IPOs in 2021

IPOs in September

Next Article

Sansera Engineering IPO gets subscribed 0.53 times at end of Day-1

Sansera IPO Subscription Status Day 1
IPO
14/09/2021

The Rs.1,282.98 crore IPO of Sansera Engineering, consisting entirely of an offer for sale or OFS, has been partially subscribed on Day-1. As per the combined bid details put out by the BSE, Sansera Engineering IPO was subscribed 0.53X overall, with bulk of the demand coming from the retail segment followed by QIB segment. 

As of close of 14 September, out of the 121.09 lakh shares on offer in the IPO, Sansera Engineering saw bids for 64.19 lakh shares. This implies an overall subscription of 0.53X. The granular break-up of subscriptions were tilted in favour of retail investors but QIB bids did make a start and the HNI bids typically come in on the last day of the issue.

Sansera Engineering IPO Subscription Day-1

Category

Subscription Status

Qualified Institutional Buyers (QIB)

0.29 Times

Non Institutional Investors (NII)

0.07 Times

Retail Individuals

0.87 Times

Employees

0.36 Times

Overall

0.53 times

 

QIB Portion

The QIB subscription was subscribed 0.29 times at the end of Day-1. On 13 September, Sansera Engineering did an anchor placement of Rs.382.05 crore to QIB investors including a number of marquee names like Government of Singapore, Monetary Authority of Singapore, Nomura, Abu Dhabi Investment Authority, Axis MF, ICICI Prudential MF, SBI Life, Max India Life, Kuber India Fund etc. The QIB portion (net of anchor allocation) has a quota of 34.23 lakh shares of which it has got bids for 10.08 lakh shares, implying a subscription ratio of 0.29X for QIBs at the end of Day-1. QIB bids typically get bunched on the last day.

HNI Portion

The HNI portion got subscribed just 0.07X (getting applications for 1.77 lakh shares against the quota of 25.68 lakh shares). Bulk of the funded applications and corporate applications, come in on the last day, so we have to wait for a clearer picture. 

Retail Individuals

The retail portion is subscribed 0.87X at the end of Day-1, showing strong retail appetite. For retail investors; out of the 59.91 lakh shares on offer, valid bids were received for 51.88 lakh shares, of which bids for 39.68 lakh shares were at the cut-off price. The IPO is priced in the band of (Rs.734-Rs744) and will close for subscription on 16th September.
 

Next Article

Vijaya Diagnostic Centre IPO lists at small premium but builds on

Vijaya Diagnostic Listing Price
IPO
14/09/2021

Vijaya Diagnostic Centre had a tepid listing on 14 September as it listed at a premium of 1.7%; much better than the discount listing indicated by the GMP. More importantly, Vijaya not only held on to the gains but also built on it. Vijaya Diagnostic Centre listed at a small premium and traded through the day in a range of Rs.100. The stock closed the day, well above the listing price. With overall subscription of over 4.54X, listing response was much better than the indications given by the subscription levels.

Here is the Vijaya Diagnostic Centre listing story on 14 September

The IPO price was fixed at the upper end of the band at Rs.531 after the 4.54X subscription. On 14 Sep, the stock of Vijaya Diagnostic Centre listed on the NSE at a price of Rs.540, a premium of 1.7% over the issue price. On the BSE, the stock listed at a price of Rs.542.30, a listing premium of 2.13%.

On the NSE, Vijaya Diagnostic Centre closed at Rs.617, a first day closing premium of an impressive 16.2% on the issue price. On the BSE, the stock closed at Rs.619.30, a first day closing premium of 16.63% on the issue price.

On Day-1 of listing, Vijaya Diagnostic Centre touched a high of Rs.648 on the NSE and a low of Rs.532.50. On Day-1, the Vijaya Diagnostic Centre stock traded a total of 221.95 lakh shares on NSE amounting to value of Rs.1,303.66 crore. On Day-1, Vijaya Diagnostic Centre was the fourth most liquid stock on the NSE by trading value.

On the BSE, Vijaya Diagnostic Centre touched a high of Rs.650.75 and a low of Rs.533.65. On BSE, the stock traded a total of 15.49 lakh shares amounting to value of Rs.92.12 crore. At the close of Day-1, Vijaya Diagnostic Centre had a market capitalization of Rs.6,315 crore with free-float market cap of jus